Submitted by Anonymous (not verified) on 23 October 2025 - 12:50
Human medicines European public assessment report (EPAR): Vimizim, elosulfase alfa, Date of authorisation: 27/04/2014, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vimizim, elosulfase alfa, Date of authorisation: 27/04/2014, Revision: 13, Status: Authorised